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Purpose: To identify the molecular defect causing Schnyder crystalline corneal dystrophy (SCCD) in a Chinese family
with bilateral corneal abnormalities.
Methods: The Chinese SCCD family was subjected to a complete ophthalmic examination that included slit-lamp
examination and slit-lamp photography to assess and document the crystalline deposits and arcus lipoides. In vivo laser
scanning confocal microscopy and Fourier-domain OCT were also performed on both eyes of SCCD patients. Blood
samples were taken for subsequent genetic analysis. The two coding exons of the UbiA prenyltransferase domain-
containing protein 1 (UBIAD1) gene were screened for mutations by direct sequencing.
Results: We report on a novel heterozygous mutation of UBIAD1, G98S, in two patients with SCCD. The identified
molecular defect cosegregates with the disease and is not found in 50 unaffected individuals. Morphological evaluation
on SCCD by in vivo laser scanning confocal microscopy and Fourier-domain OCT highlighted pathological observations
at the level of Bowman’s membrane and anterior stroma.
Conclusion: The newly identified mutation expands the spectrum of mutations in UBIAD1 that may cause pathological
corneal cholesterol deposition. Observations by in vivo laser scanning confocal microscopy and Fourier-domain OCT
were consistent with the previous histopathologic descriptions of SCCD.
Schnyder crystalline corneal dystrophy (SCCD; OMIM
121800) is an autosomal dominant disorder that results in
clouding of the central cornea and premature development of
peripheral arcus in the cornea. The clinical appearance of this
dystrophy varies, but it is characterized by corneal stromal
cholesterol  deposition,  most  commonly  in  an  axially
distributed,  annular  or  discoid  pattern.  The  deposits  are
predominantly located in the anterior one-third of the stroma
and Bowman’s membrane and are accompanied by a diffuse,
gray stromal haze. Despite the name, Schnyder crystalline
corneal  dystrophy,  only  about  half  of  the  patients  have
detectable crystalline deposition in the cornea. The diagnosis
of the disease in the absence of crystals is more challenging
and has been reported to be delayed up to the fourth decade
of life [1]. Progressive corneal clouding may be associated
with loss of corneal sensation. Loss of corneal nerves has been
demonstrated  by  confocal  microscopy  [2].  Eventually,
phototherapeutic keratectomy or penetrating keratoplasty is
required  for  recovery  of  corneal  clarity  and  visual
rehabilitation [3]. The dystrophy is considered rare, with less
than 150 articles in the published literature, and most articles
reporting only a few affected persons.
A  genome-wide  DNA  linkage  analysis  in  two  large
SCCD  families  of  Swede-Finn  descent  established  a  16
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centimorgan (cM) interval between markers D1S2633 and
D1S228  on  chromosome  1p36  as  the  the  chromosomal
segment harboring the putative casual gene [4]. Theendakara
et al. [5] further refined the SCCD locus using families of
multiple ethnicities, reducing the candidate region to a 2.32
Mbp interval lying between genetic markers D1S1160 and
D1S1635, or possibly a smaller 1.57 Mbp interval between
D1S244 and D1S3153. Aldave et al. [6] and Yellore et al.
[7] have reported sequencing of all annotated genes within the
2.32  Mbp  interval,  finding  no  pathogenic  mutations  and
tentatively  excluding  them  as  causing  SCCD,  a  finding
proposed to result from locus heterogeneity, mutations within
promoter  or  untranslated  regions,  the  presence  of  an
unannotated  gene,  or  an  error  in  the  assignment  of  the
candidate locus for SCCD due to misclassification of disease
status in family members. Indeed, reanalysis of the pedigrees
reported in an article by Theendakara et al. [5] showed a
misclassification in one individual. The family which this
individual belonged to had been used to define the centromeric
boundary of the candidate interval at D1S1635. Weiss et al.
[8] removed this family from the analysis and reevaluated the
haplotypes in the other families. This resulted in a shift of the
centromeric boundary of the candidate interval from D1S1635
to  D1S2667.  The  expanded  candidate  interval  included
C1orf127 (chromosome 1 open reading frame 127), TARDBP
(TAR DNA binding protein), MASP2 (mannan-binding lectin
serine peptidase 2), SRM (spermidine synthase), EXOSC10
(exosome component 10), FRAP1 (FK506 binding protein 12-
rapamycin associated protein 1), ANGPTL7 (angiopoietin-
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1463like  7),  UBIAD1,  and  LOC39906.  Recently,  Orr  and
coworkers [9] reported that mutations in the UBIAD1 gene
resulted in SCCD. UBIAD1 spans 22 kb and the locus contains
up to five exons with potentially several different transcripts.
Up to date, mutations have only been described in exon1 and
2 which form a discrete transcript encoding a protein with a
predicted  prenyl  transferase  domain  and  up  to  eight
transmembrane spanning regions.
Eleven different UBIAD1 mutations causing SCCD have
been  reported  to  date  [7-10],  predominantly  in  Caucasian
patients. Molecular genetic analysis of patients from diverse
ethnic  backgrounds  showed  both  genetic  and  allelic
heterogeneity for SCCD.
In  the  present  study  we  report  the  molecular  genetic
analysis of UBIAD1 in a Chinese family with SCCD, in which
a novel UBIAD1 mutation was identified. To our knowledge
this is the first report of SCCD with novel gene mutation found
in family from the mainland of China.
METHODS
This study was approved by the Institutional Review Board
of the Henan Eye Institute. Informed consent in accord with
the Declaration of Helsinki was obtained from the patients and
their family members who participated in this study.
Report of cases:
SCCD  Case  1—A  29-year-old  Chinese  woman  (the
proband) was referred to our department in November, 2008
with symptoms of photophobia and vision decrease for about
1 year. Her best-corrected visual acuity (BCVA) in a lit room
was 20/20 in the right eye and 20/100 in the left eye. Under
slit-lamp examination, the right cornea presented with far less
crystalline deposition than in left eye, but the central area
showed mild anterior stromal haze. The left cornea showed
typical  central  subepithelial  crystalline  deposits.  The
Figure  1.  Slit-lamp  photographs  of
affected  patients  eyes.  A:  The  right
cornea  of  the  29-year-old  Chinese
woman shows punctiform deposition of
subepithelial crystals, central haze, and
arcus lipoides. B: Appearance of her left
cornea demonstrates a central plaque of
subepithelial crystals slightly inferiorly
displaced  in  the  visual  axis,
midperipheral  clouding,  and  arcus
lipoides. C: Slit-lamp photograph of left
eye  (OS)  demonstrating  subepithelial
crystalline deposits. D: The right cornea
of the 54-year-old man shows central
panstromal disc-like opacity obscuring
the pupillary axis, and prominent arcus
lipoids.  E,  F:  Anterior  stromal
disciform opacity with arcus lipoides is
observed in his left eye. No crystals are
apparent in the corneal stroma.
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1464paracentral cornea was clear, but prominent arcus lipoids were
present in both eyes. The deposits were composed of a fine,
lacy garland of crystals present primarily in the anterior aspect
of the stroma just beneath Bowman’s membrane (Figure 1A-
C). Cochet-Bonnet esthesiometer was used to measure the
corneal  sensitivity  and  revealed  no  decrease  of  corneal
sensation  in  both  corneas.  Intraocular  pressures  were  16
mmHg  and  the  ocular  examination  was  otherwise
unremarkable.
Genu valgum has been postulated to be an independent
trait reported in association with SCCD. Both the physical
exam and radiography of knee joints demonstrated bilateral
genu valgus in the patient. The blood serum level of total
cholesterol was marginally elevated, as were levels of low-
density lipoprotein, apolipoprotein A1, and apolipoprotein B.
Triglycerides and high-density lipoprotein were normal.
SCCD Case 2—A 54-year-old man, the father of the
proband, was seen in our department in April, 2009 with
bilateral SCCD. He presented with similar symptoms as the
proband. Best-corrected visual acuity was 10/20 in the right
eye and 20/25 in the left eye. The patient didn’t seek medical
attention  until  this  point.  Pupillary  reaction,  intraocular
pressure, ocular motility, and fundus examination results were
normal. Slit-lamp examination of both corneas demonstrated
a  mild  central  panstromal  disc-like  opacity  obscuring  the
pupillary axis, and prominent arcus lipoids. These clinical
changes  were  more  prominent  in  the  right  eye.  A  clear
midperipheral corneal stroma was noted between the central
disc-like  opacity  and  the  arcus  (Figure  1D-F).  Corneal
sensation  was  normal  in  both  eyes.  Fasting  lipid  profiles
identified elevated serum cholesterol.
Mutation  Analysis:  Molecular  genetic  analyses  were
performed in the two patients and unaffected family members:
members II:2, III:1, and III:3 from this family (Figure 2A).
Fifty healthy Chinese subjects were examined as controls.
Genomic  DNA  was  obtained  from  peripheral  blood
leukocytes  according  to  standard  procedures.  For
amplification of the exon1 and exon2 of UBIAD1; primer pairs
were used as designed by Yellore et al. [7]. Their sequences
are as follows: UBIAD1; F1/R1, 5’-CTC GTG GGG TGT
AAG ACC CAC TT-3’/5’-GCG GCT TAA ATT AGA AAG
CCA CCT-3’, UBIAD1; F2/R2, 5’-AGT GCC CAC CTG
CAC AGT CTA AG-3’/5’-CAA ACT GGG CAG CTC CTT
TAC AA-3’. The sizes of the amplified DNA fragments were
819 bp and 979 bp, respectively.
Each polymerase chain reaction (PCR ) was performed
in a 50 μl reaction mixture consisting of genomic DNA (100
ng ), dNTP mixture (200μM ), 25μl 2X GC buffer I with
MgCl2, forward and reverse primer (0.1μM each ) and 2.5 U
Hotstar Taq polymerase (Qiagen, Hilden, Germany ). GC
buffer was provided by Takara Biotechnology (Dalian) CO.
Ltd.  (Liaoning,  China)  and  designed  for  amplification  of
templates having complex secondary structure or high GC
Figure 2. Novel UBIAD1 mutation in the study family. A: Pedigree
of the study family. In the family tree, squares indicate male and
circles indicate female of the family members. Slash denote family
member  who  was  deceased,  whereas  heavy  shading  means  the
individual who was affected by SCCD. Arrow indicates proband.
B: Sequence chromatogram of the proband and her father showing
heterozygous mutation G98S in exon 1, forward reading. C: Reverse
reading of the same mutation, showing G98S. D: Normal sequence of
UBIAD1 near codon 98, forward reading. E: Normal sequence of
UBIAD1 near the mutation in antisense strands detected in a healthy
control. F: Sequence alignment of UBIAD1 around the amino acid
residues of the mutation detected in the present study and in other
species.
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content. Amplification reactions were performed under thefollowing conditions: 4 min of denaturation at 95 °C followed
by 30 cycles of denaturation at 94 °C for 30 s, annealing at 55
°C to 60 °C for 30 s, extension at 72 °C for 30 s, and a further
extension step at 72 °C for 8 min. For direct sequencing, PCR
products were purified using the QIAquick PCR purification
kit (Qiagen), cycle sequenced with a Big Dye Terminator
cycle sequencing kit (Applied Biosystems, Foster City, CA )
and directly sequenced on both strands using an automatic
DNA sequencer (ABI Prism 377 Genetic Analyser; Applied
Biosystems) according to the manufacturer’s instructions.
Nucleotide sequences were compared with the published
cDNA sequence of UBIAD1 (GenBank NM_013319.2) for
each exon.
Confocal  microscopy  and  Fourier-domain  OCT
analysis:  In  this  study,  we  coupled  in  vivo  confocal
microscopy  and  Fourier-domain  optical  coherence
tomography (OCT) to evaluate the morphological changes of
the cornea in patients with SCCD.
After a detailed explanation, a laser scanning in vivo
confocal microscopy with a diode laser of 670 nm wavelength
(HRT3/RostockCorneaModule;  Heidelberg  Engineering,
Dossenheim, Germany) was performed on both eyes of the
SCCD  patients.  Two-dimensional  confocal  images  of  the
different  corneal  layers  were  acquired.  Subsequently,  the
corneas of the proband were scanned three times with two scan
patterns, the line scan and the cross-line scan, by a high-speed,
high-resolution,  Fourier-domain  optical  coherence
tomography (Optovue Inc, Fremont, CA).We chose the best
of the three scans for analysis.
RESULTS
Mutation Analysis: Direct sequencing analysis of UBIAD1
exon  1  in  the  proband  and  her  father  revealed  a  single
heterozygous base pair transition at nucleotide position 292
(G→A), which converts a Glycine at codon 98 into a Serine,
shown in Figure 2B. This mutation was confirmed by analysis
of the reverse sequence data and has not previously been
identified in SCCD (Figure 2C). The unaffected members of
this family and normal controls didn’t have the mutation as
determined by direct sequencing (Figure 2D,E). Therefore,
the identified molecular defect cosegregates with the disease
in this family.
Confocal microscopy and Fourier-domain OCT Analysis: In
vivo  laser  scanning  confocal  microscopy  revealed
pathological alterations of the normal corneal anatomy in the
patients. Abnormal subepithelial nerve plexus were found in
Bowman’s membrane, presenting with an irregular curved
appearance  and  prominent  beam-like  structures.  Large
accumulations of brightly reflective crystalline material were
noted in Bowman’s membrane. The anterior stroma showed
the  presence  of  multiple  deposits  of  brightly  reflective
crystalline material extending from the anterior to the mid
stroma. The shapes of the crystals were needle-shaped or
rectangular (Figure 3A-C). However, the crystals were not
apparent in both eyes of the father. The images acquired from
Fourier-domain  optical  coherence  tomography  (OCT)
indicated that the main presence of crystalline deposits was
localized within the anterior stroma, extending from the basal
epithelium layer to a depth of 100 to 150 µm (Figure 4).
DISCUSSION
SCCD is a rare autosomal dominant disorder that usually
appears in the first or second decade of life. Up to date, only
two patients with SCCD were reported from China (Taiwan),
with heterozygous mutations (N102S, G177R). N102S is the
most frequent mutation found in Caucasian SCCD patients
with either European or unknown ethnicity [10]. Our patients
are from a family in the central region of China, and the
mutation is found to be novel. Moreover, our patients have no
ethnic relationship with the Caucasian.
Of 28 unrelated SCCD-affected families with UBIAD1
mutations reported previously, 11 different mutations have
Figure 3. In vivo laser scanning confocal microscopic findings for the proband. A, B: Brightly reflective deposition, presumably cholesterol
or lipid, is associated with the subepithelial nerve fibers in the left cornea. The shapes of the crystals were needle-shaped or rectangular. C:
Anterior stroma showed the presence of multiple deposits of brightly reflective crystalline material. The keratocyte nuclei are undetectable.
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1466been  reported  (N102S,  D112G,  G117R,  D118G,  R119G,
L121F,  S171P,  T175I,  G186R,  N232S,  and  D236E).  The
novel mutation identified in this study demonstrates further
mutational heterogeneity. Studies of the genetic basis of the
corneal `dystrophies have revealed that most reported cases
of  SCCD  are  caused  by  amino  acid  substitutions  within
UBIAD1, and most reported mutations have been missense
mutations. The novel mutation identified in our current study
is also a heterozygous missense mutation, and the site of the
mutation is unique. The G98S mutation converts a Glycine at
codon 98 into a Serine. The amino acid substitutions described
as mutations in SCCD patients were examined for charge,
size, and hydrophobicity to understand the consequences of
these  mutations  on  the  UBIAD1  protein  structure  and
function. Many of the mutations reported in prior studies were
nonconservative  amino  acid  substitutions.  There  were
dramatic size and/or shape differences between the reference
sequence  and  mutant  amino  acids  in  these  mutations.
Interestingly, the mutation locations identified in our study as
well as prior publications revealed several clusters identified
as loops 1, 2, or 3 when shown in a two-dimensional modeling
[10]. Our novel mutation is located in loop 1, and this mutation
seems to occur in parts of the protein located on one side of
the  membrane.  Additionally,  all  mutations  fall  either  in
aqueous portions of the UBIAD1 protein or transmembrane
helices close to one face of the lipid bilayer. However, it is
unknown why mutation clusters are located on one side of the
membrane. As shown in sequence alignment of the putative
ligand/polyprenyldiphosphate binding site in loop 1 (Figure
2F), the mutation found in this study, G98, has been highly
conserved among many species, indicating the importance of
these proteins.
UBIAD1 produces a protein that is predicted to contain a
prenyltransferase  domain  and  up  to  eight  transmembrane
spanning  regions  that  could  play  a  role  in  cholesterol
metabolism. This gene is variably expressed in a wide variety
of  tissues,  but  its  expression  as  measured  by  expressed
sequence tag (EST) counts is higher in the eye than in any
other  tissue  (UniGene’s  EST  Profile  Viewer).  Although
UBIAD1 has been found to be expressed in the adult human
cornea (NEIBank library NbLib0073), the role of mutations in
UBIAD1 in the pathogenesis of SCCD is not well understood
[7]. UBIAD1 can interact with the COOH-terminal portion of
apoE  [11],  which  is  known  to  be  involved  in  cholesterol
transport, especially in mediating solubilization and in the
removal of cholesterol from cells [12]. Hence, there is an
obvious  association  between  a  defect  in  UBIAD1  and
cholesterol transportation. However, UBIAD1 also contains
the prenyltransferase domain, which is involved in cholesterol
synthesis. Therefore, a defect in UBIAD1 may be associated
with an increase in local cholesterol synthesis. The major
weakness  of  this  study  is  the  small  number  of  patients.
Figure 4. Fourier-domain OCT findings
of the proband’s left cornea. Shown is
the  presence  of  crystalline  deposits
localized within the anterior stroma in
OS. The highest density of crystalline
deposits  seemed  to  be  mainly  in  the
anterior stroma, within the first 100 µm
of the corneal depth.
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described in this study on UBIAD1 protein function should
be investigated in future study.
Though  considerable  phenotypic  variation  has  been
reported, the phenotype-genotype correlation is not clear. It
still  needs  to  be  determined  if  the  mutational  pattern  is
correlated with the clinical course, or may be a prognostic
indicator. As in our study, the proband and her father both had
a G98S mutation, the 29-year-old proband had predominantly
central ring pattern of crystalline deposition and her father had
predominantly corneal opacity without crystals. The existence
and nonexistence of crystals was confirmed by in vivo laser
scanning  confocal  microscopy.  A  ring  pattern  of  corneal
crystalline deposition was noted in individuals of different
ages and with different mutations. These findings demonstrate
further  the  phenotypic  heterogeneity  and  mutational
heterogeneity in SCCD. It is possible that the phenotypic
heterogeneity resulted from modulating influences such as
environmental effects or that a specific phenotype may be a
result of the interaction of multiple genes.
Recently, with the development of more sophisticated
corneal imaging modalities, the microstructure of the living
cornea can be observed in situ throughout the disease course,
rather than only at the end-stage. The information gained from
these  techniques  has  enhanced  our  understanding  of  the
pathophysiological  mechanisms  at  play  in  the  disparate
disease entities. Confocal microscopy and Fourier-domain
optical coherence tomography (OCT) are new emerging non-
invasive  technologies,  which  are  useful  as  supplementary
diagnostic tool for in vivo assessment of the histopathology
of  many  ocular  surface  diseases  and  anterior-segment
disorders. Our morphological evaluation on SCCD by in vivo
laser scanning confocal microscopy and Fourier-domain OCT
will not only clarify the pathological changes of this disease
but serve to further clarify the clinical findings of this disease.
In the presented cases, clinically diagnosed as SCCD, in vivo
laser scanning confocal microscopy and Fourier-domain OCT
highlighted observations at the level of Bowman’s membrane
and anterior stroma, which is consistent with the result of the
previous  histological  study  of  SCCD  [13-15].  However,
observations obtained by these two techniques are neither
completely comparable with established clinical observations
using the slit-lamp biomicroscope, nor with the structural
descriptions of established ex vivo microscopical techniques.
Therefore, clinical researchers will continue to report new
descriptions, of this disease, using these two contemporary
technologies.
In summary, our data add a novel mutation identified in
a Chinese family with SCCD to the existing spectrum of
UBIAD1 gene mutations. Despite the rarity of this corneal
dystrophy,  the  fact  that  affected  Chinese  family  also  has
mutation in UBIAD1 provides another evidence to support the
hypothesis  that  SCCD  is  possibly  caused  by  UBIAD1
mutations.
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